Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Compare capital gains tax exposure between ETFs and index funds in retirement, and choose the option with better tax efficiency.
28,430 articlesEli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
The GLP-1 wave has traders buzzing. While Lilly and Novo Nordisk hold steady as reliable bets, smart portfolios tap i...
Bitcoin price drops as the Fed leaves rates steady under new Chair Kevin Warsh, triggering intraday volatility and be...
June 2026 opens with a handful of beaten-down stocks that could roar back as inflation cools and earnings beat expect...
Pump.fun has unveiled a record-setting compensation package for its Chief Legal Officer, signaling a competitive push...
A rising figure in Iran’s shadow government, Mojtaba Khamenei is fueling a debate over who will lead and how the econ...
Market observers say political shocks, energy costs, and shifting policy paths are creating a fragile backdrop for ho...
Intercontinental Exchange sits at the heart of global markets, combining exchanges, data, and clearing. This piece ex...
Iraq restarts crude shipments via the Iraq-Turkey pipeline, nudging global oil prices lower as traders reassess suppl...
NVIDIA hits fresh highs after U.S. regulators approve more H200 chip sales to China, lifting momentum across the AI c...
Nu Holdings signals growing resilience as it posts a record Q1. This deep dive explains what the results mean for NU ...
Oil majors are again tightening the net on mid-cap energy producers. Three energy plays stand out as takeover candida...